These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11410934)

  • 1. The active site of HIV-1 protease.
    Mager PP
    Med Res Rev; 2001 Jul; 21(4):348-53. PubMed ID: 11410934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the dimeric triad of HIV-1 aspartyl protease with inhibitors.
    Mager PP; De Clercq E; Froeyen M; Reinhardt R
    Drug Des Discov; 2003; 18(2-3):53-64. PubMed ID: 14675943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionization state of the catalytic dyad Asp25/25' in the HIV-1 protease: NMR studies of site-specifically 13C labelled HIV-1 protease prepared by total chemical synthesis.
    Torbeev VY; Kent SB
    Org Biomol Chem; 2012 Aug; 10(30):5887-91. PubMed ID: 22659831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A density functional study of the hydrogen-bond network within the HIV-1 protease catalytic site cleft.
    Sirois S; Proynov EI; Truchon JF; Tsoukas CM; Salahub DR
    J Comput Chem; 2003 Jul; 24(9):1110-9. PubMed ID: 12759910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site binding modes of curcumin in HIV-1 protease and integrase.
    Vajragupta O; Boonchoong P; Morris GM; Olson AJ
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3364-8. PubMed ID: 15950462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations.
    Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Sanghiran V; Parasuk V; Hannongbua S
    J Mol Graph Model; 2006 Nov; 25(3):324-32. PubMed ID: 16504560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.
    Wang YX; Freedberg DI; Yamazaki T; Wingfield PT; Stahl SJ; Kaufman JD; Kiso Y; Torchia DA
    Biochemistry; 1996 Aug; 35(31):9945-50. PubMed ID: 8756455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors.
    Karpoormath R; Sayed Y; Govender P; Govender T; Kruger HG; Soliman MES; Maguire GEM
    Bioorg Chem; 2012 Feb; 40(1):19-29. PubMed ID: 21982718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational flexibility of the catalytic Asp dyad in HIV-1 protease: An ab initio study on the free enzyme.
    Piana S; Carloni P
    Proteins; 2000 Apr; 39(1):26-36. PubMed ID: 10737924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing the reaction pathway in near-atomic-resolution crystal structures of HIV-1 protease.
    Shen CH; Tie Y; Yu X; Wang YF; Kovalevsky AY; Harrison RW; Weber IT
    Biochemistry; 2012 Oct; 51(39):7726-32. PubMed ID: 22963370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
    Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
    Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active-site mobility in human immunodeficiency virus, type 1, protease as demonstrated by crystal structure of A28S mutant.
    Hong L; Hartsuck JA; Foundling S; Ermolieff J; Tang J
    Protein Sci; 1998 Feb; 7(2):300-5. PubMed ID: 9521105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, screening and computational investigation of pentacycloundecane-peptoids as potent CSA-HIV PR inhibitors.
    Makatini MM; Petzold K; Arvidsson PI; Honarparvar B; Govender T; Maguire GE; Parboosing R; Sayed Y; Soliman ME; Kruger HG
    Eur J Med Chem; 2012 Nov; 57():459-67. PubMed ID: 22867528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease.
    Pawar SA; Jabgunde AM; Govender P; Maguire GE; Kruger HG; Parboosing R; Soliman ME; Sayed Y; Dhavale DD; Govender T
    Eur J Med Chem; 2012 Jul; 53():13-21. PubMed ID: 22542107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Mutations Can Resist Drug Binding yet Keep HIV-1 Protease Functional.
    Appadurai R; Senapati S
    Biochemistry; 2017 Jun; 56(23):2907-2920. PubMed ID: 28505418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the S1/S1' substrate binding pocket geometry of HIV-1 protease with modified aspartic acid analogues.
    Short GF; Laikhter AL; Lodder M; Shayo Y; Arslan T; Hecht SM
    Biochemistry; 2000 Aug; 39(30):8768-81. PubMed ID: 10913288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural stability of the HIV-1 protease.
    Todd MJ; Semo N; Freire E
    J Mol Biol; 1998 Oct; 283(2):475-88. PubMed ID: 9769219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic water co-existing with a product peptide in the active site of HIV-1 protease revealed by X-ray structure analysis.
    Prashar V; Bihani S; Das A; Ferrer JL; Hosur M
    PLoS One; 2009 Nov; 4(11):e7860. PubMed ID: 19924250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caught in the Act: the 1.5 A resolution crystal structures of the HIV-1 protease and the I54V mutant reveal a tetrahedral reaction intermediate.
    Kovalevsky AY; Chumanevich AA; Liu F; Louis JM; Weber IT
    Biochemistry; 2007 Dec; 46(51):14854-64. PubMed ID: 18052235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.